Division of Interventional Cardiology, Cardiology Department, Albert Einstein Medical Center, Philadelphia, PA 19141 USA.
J Invasive Cardiol. 2020 Jan;32(1):1-4. doi: 10.25270/jic/19.00232.
There is increasing burden of peripheral arterial disease (PAD) in the United States. Despite advancements in endovascular therapy, there have been significant limitations in invasive interventions aimed at revascularization. The transpedal tibial artery retrograde approach has been described as an alternative access for patients with complex disease requiring dual access or failed revascularization via conventional common femoral artery access. In this study, we examined the safety and efficacy of a radial hemostatic band to achieve hemostasis post procedure without compromising the integrity of the accessed tibial artery.
This study included 20 patients with PAD requiring endovascular revascularization on whom the RadAR band device (Advanced Vascular Dynamics) was applied for postprocedure hemostasis following transpedal access between December 2011 and May 2014. All patients underwent routine postprocedure ankle-brachial indices (ABIs) following hemostasis to determine outcomes of the overall ABI and that of the accessed pedal artery.
Mean patient age was 77 years and mean patient weight was 80.9 kg. Mean follow-up was 11 months post procedure. Lesions were located as follows: 3 popliteal, 13 superficial femoral, 3 posterior tibial, and 1 anterior tibial. Nine procedures were performed on the left leg and 11 on the right leg. All patients received heparin as anticoagulation, with a targeted activated clotting time between 250-300 seconds. Access was made into the posterior tibial in 15 patients and in the anterior tibial in 5 patients. RadAR band was deployed in a fashion similar to its deployment on the radial artery. Hemostasis was achieved in all 20 cases without complication. Postprocedure ABI and pedal-brachial index (PBI) improved significantly compared with the preprocedure values. There was an average improvement of approximately 50% in ABIs, improving from 0.59 to 0.88. The PBI also improved from 0.59 before the procedure to 0.87 post procedure. There was, however, no significant difference in ABI or PBI in anterior vs posterior tibial artery access patients.
Transpedal tibial arterial access is an effective technique for revascularization in the lower extremity, and postprocedure access-vessel hemostasis and patency are reliably and safely achieved using a hemostatic band device.
外周动脉疾病(PAD)在美国的负担越来越重。尽管腔内治疗取得了进展,但针对再血管化的有创介入治疗仍存在显著局限性。经皮足背胫动脉逆行入路已被描述为一种替代方法,适用于需要双入路或经传统股总动脉入路再血管化失败的复杂疾病患者。在这项研究中,我们研究了一种桡动脉止血带的安全性和有效性,该止血带可在经皮足背入路后实现术后止血,同时不影响所接入的胫动脉的完整性。
这项研究纳入了 20 例需要血管内再血管化的 PAD 患者,这些患者于 2011 年 12 月至 2014 年 5 月期间接受了经皮足背入路治疗,在治疗后应用 RadAR 带(先进血管动力学)装置实现止血。所有患者在止血后均接受常规术后踝肱指数(ABI)检查,以确定总体 ABI 和所接入的足背动脉的结果。
患者平均年龄为 77 岁,平均体重为 80.9kg。平均随访时间为术后 11 个月。病变部位如下:3 例腘动脉,13 例股浅动脉,3 例胫后动脉,1 例胫前动脉。9 例手术在左腿进行,11 例在右腿进行。所有患者均接受肝素抗凝,目标激活凝血时间为 250-300 秒。15 例患者经皮足背胫后动脉入路,5 例患者经皮足背胫前动脉入路。RadAR 带的部署方式与桡动脉类似。20 例患者均成功止血,无并发症。与术前相比,术后 ABI 和足趾-肱指数(PBI)显著改善。ABI 平均提高约 50%,从 0.59 提高到 0.88。PBI 也从术前的 0.59 提高到术后的 0.87。然而,在前、后胫动脉入路患者中,ABI 或 PBI 无显著差异。
经皮足背胫动脉入路是下肢再血管化的有效技术,采用止血带装置可可靠、安全地实现术后入路血管止血和通畅。